EurekaMag.com logo
+ Site Statistics
References:
47,893,527
Abstracts:
28,296,643
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

13-cis-Retinoic acid plus interferon- alpha 2a in recurrent respiratory papillomatosis


, : 13-cis-Retinoic acid plus interferon- alpha 2a in recurrent respiratory papillomatosis. Journal of the National Cancer Institute 86(11): 859-861

The use of 13-cis-retinoic acid and interferon- alpha 2a in the treatment of recurrent respiratory papillomatosis are discussed.


Accession: 002549714

PMID: 8182767

Submit PDF Full Text: Here


Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:
Close
Close

Related references

Lippman, S.M.; Donovan, D.T.; Frankenthaler, R.A.; Weber, R.S.; Earley, C.L.; Hong, W.K.; Goepfert, H., 1994: 13-Cis-retinoic acid plus interferon-alpha 2a in recurrent respiratory papillomatosis. The use of 13-cis-retinoic acid and interferon- alpha 2a in the treatment of recurrent respiratory papillomatosis are discussed.

Gerein, V.; Rastorguev, E.; Gerein, J.; Jecker, P.; Pfister, H., 2005: Use of interferon-alpha in recurrent respiratory papillomatosis: 20-year follow-up. Objectives: The aim of this study was analysis of the results of use of interferon-alpha (IFN-alpha) in patients with recurrent respiratory papillomatosis (RRP) and correlation of the results with human papillomavirus (HPV) type.Methods: A multice...

Bell, R.; Hong, W.K.; Itri, L.M.; McDonald, G.; Strong, M.S., 1988: The use of cis-retinoic acid in recurrent respiratory papillomatosis of the larynx: a randomized pilot study. We undertook a study of 13-cis-retinoic acid to evaluate its use as an adjuvant to laser surgery in the management of recurrent respiratory papillomatosis. In a double-blind study using placebo, four of the six subjects treated with this agent exp...

Weiss, G.R.; Liu, P.Y.; Alberts, D.S.; Peng, Y.M.; Fisher, E.; Xu, M.J.; Scudder, S.A.; Baker, L.H.; Moore, D.F.; Lippman, S.M., 1999: 13-cis-retinoic acid or all-trans-retinoic acid plus interferon-alpha in recurrent cervical cancer: a Southwest Oncology Group phase II randomized trial. Preclinical and clinical data support the study of retinoids and interferon-alpha (IFN-alpha) in advanced squamous cell carcinoma of the uterine cervix (SCC). This phase II randomized trial of the Southwest Oncology Group sought to estimate the re...

Gerein V.; Desloovere C.; Lodemann E.; Kornhuber B.; Draf W.; Von Ilberg C., 1989: Long term alpha interferon treatment of recurrent respiratory papillomatosis following an individualized dosage scheme. Archives of Oto-Rhino-Laryngology 246(6): 459

Benjamin, B.N.; Gatenby, P.A.; Kitchen, R.; Harrison, H.; Cameron, K.; Basten, A., 1988: Alpha-interferon (Wellferon) as an adjunct to standard surgical therapy in the management of recurrent respiratory papillomatosis. Ten patients received lymphoblastoid alpha-interferon (Wellferon) in a crossover study so that Wellferon and standard microsurgical laryngeal laser therapy could be compared to laser therapy alone. Wellferon was administered initially at an intrav...

Pluzhnikov, M.S.; Katinas, E.B.; Riabova, M.A.; Karpishchenko, S.A.; Totolian, A.A., 2008: Efficacy of local use of recombinant interferon alpha-2 preparations in combined treatment of recurrent respiratory papillomatosis. Clinical-immunological examination of 41 patients with recurrent respiratory papillornatosis (RRP) included determination of phenotype CD3, CD4, CD8, CD16, CD25, CD56, HLA-DR in peripheral blood by flow cytofluorimetry, the levels of IFNgamma, TN...

Nodarse-Cuní, H.; Iznaga-Marín, N.; Viera-Alvarez, D.; Rodríguez-Gómez, H.; Fernández-Fernández, Héctor.; Blanco-López, Yín.; Viada-González, C.; López-Saura, P., 2004: Interferon alpha-2b as adjuvant treatment of recurrent respiratory papillomatosis in Cuba: National Programme (1994-1999 report). Respiratory papillomatosis is a life-spoiling disease due to its high recurrence rate. Interferon (IFN) alpha-2b treatment, adjuvant to surgery, was assessed for its contribution to disease control and patient quality of life improvement. One hund...

Szeps, M.; Dahlgren, L.; Aaltonen, L-Maija.; Ohd, J.; Kanter-Lewenshon, L.; Dahlstrand, H.; Munck-Wikland, E.; Grandér, D.; Dalianis, T., 2005: Human papillomavirus, viral load and proliferation rate in recurrent respiratory papillomatosis in response to alpha interferon treatment. The aim of this study was to identify recurrent respiratory papillomatosis patients who may benefit from interferon (IFN)-alpha treatment and to determine the means of IFN-alpha action. The presence of human papillomavirus (HPV) and viral load and...

Grigorian, S.S.; Pritzker, A.D.; Chireshkin, D.G.; Ershov, F.I., 1992: Interferon system and circulating immunoglobulins in recurrent respiratory papillomatosis during interferon therapy. Journal of Interferon Research 12(SUPPL 1): S148